產(chǎn)品名稱(chēng) | 周期素D1抗體 |
英文名稱(chēng) | Anti-CyclinD1 |
規(guī)格 | 0.1ml/100μg 0.2ml/200μg 1ml/1mg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱(chēng) Anti-Cyclin D1
中文名稱(chēng) 周期素D1抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg 1ml/1mg
抗體來(lái)源 Rabbit
交叉反應(yīng) Human, Mouse, Rat, Dog,
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 腫瘤 細(xì)胞生物 細(xì)胞周期蛋白
蛋白分子量 predicted molecular weight: 32kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanCyclin D1 N-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -20 °C for one year.
別 名 Cyclin D1; CyclinD1; Cyclin-D1; B cell ccl/lymphoma1; B cell leukemia 1; B-cell CLL/lymphoma 1; B-cell leukemia 1; B-cell lymphoma1 protein; BCL-1; BCL1; BCL1 oncogene; CCND 1; CCND1; CCND1 protein;CCND1/FSTL3 fusion gene, included; CCND1/IGHG1 fusion gene; CCND1/IGHG1 fusiongene, included; CCND1/IGLC1 fusion gene, included; CCND1/PTH fusion gene,included; Parathyroid adenomatosis 1; PRAD1; FSTL3; CCND1_HUMAN; AI327039; Bcell lymphoma 1 protein; BCL 1; BCL-1; BCL-1 oncogene; BCL1 oncogene; CCND1/FSTL3fusion gene, included; cD1; Cyl 1; D11S287E; G1/S specific cyclin D1;G1/S-specific cyclin-D1.
